JP2024534499A5 - - Google Patents

Info

Publication number
JP2024534499A5
JP2024534499A5 JP2024517427A JP2024517427A JP2024534499A5 JP 2024534499 A5 JP2024534499 A5 JP 2024534499A5 JP 2024517427 A JP2024517427 A JP 2024517427A JP 2024517427 A JP2024517427 A JP 2024517427A JP 2024534499 A5 JP2024534499 A5 JP 2024534499A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
recombinant polypeptide
polypeptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024517427A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534499A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076862 external-priority patent/WO2023049803A1/en
Publication of JP2024534499A publication Critical patent/JP2024534499A/ja
Publication of JP2024534499A5 publication Critical patent/JP2024534499A5/ja
Pending legal-status Critical Current

Links

JP2024517427A 2021-09-22 2022-09-22 Il5ra細胞表面マーカー Pending JP2024534499A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163247239P 2021-09-22 2021-09-22
US63/247,239 2021-09-22
PCT/US2022/076862 WO2023049803A1 (en) 2021-09-22 2022-09-22 Il5ra cell surface markers

Publications (2)

Publication Number Publication Date
JP2024534499A JP2024534499A (ja) 2024-09-20
JP2024534499A5 true JP2024534499A5 (cg-RX-API-DMAC7.html) 2025-09-30

Family

ID=85721256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024517427A Pending JP2024534499A (ja) 2021-09-22 2022-09-22 Il5ra細胞表面マーカー

Country Status (9)

Country Link
US (1) US20240417443A1 (cg-RX-API-DMAC7.html)
EP (1) EP4405383A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024534499A (cg-RX-API-DMAC7.html)
KR (1) KR20240069766A (cg-RX-API-DMAC7.html)
CN (2) CN118251407A (cg-RX-API-DMAC7.html)
AU (1) AU2022349077A1 (cg-RX-API-DMAC7.html)
CA (1) CA3232203A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024003250A (cg-RX-API-DMAC7.html)
WO (1) WO2023049803A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121538180A (zh) * 2025-11-28 2026-02-17 中国医学科学院肿瘤医院 经修饰的单核细胞、其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor
DE60112282T2 (de) * 2000-05-22 2006-04-20 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Auf rezeptorgrundlage arbeitende screening-verfahren für protein wechselwirkungen
PT3072525T (pt) * 2007-05-14 2018-04-20 Astrazeneca Ab Métodos para reduzir os níveis de basófilos
ES3053874T3 (en) * 2015-08-24 2026-01-27 Glaxosmithkline Ip No 2 Ltd Biopharmaceutical compositions
HK1255922A1 (zh) * 2015-11-04 2019-09-06 Astrazeneca Ab 二肽基肽酶-4和骨膜素作为嗜酸性粒细胞疾病中嗜酸性粒细胞靶向治疗药物临床反应的预测因子
EP3635132A4 (en) * 2017-06-07 2021-05-26 Intrexon Corporation EXPRESSION OF NOVEL CELL MARKERS
IL296242A (en) * 2020-03-10 2022-11-01 Massachusetts Inst Technology Methods for generating engineered memory-like nk cells and compositions thereof

Similar Documents

Publication Publication Date Title
CN110818802B (zh) 一种嵌合t细胞受体star及其应用
JP2865300B2 (ja) ヒトb細胞刺激因子2レセプター蛋白質
JP2021191265A5 (cg-RX-API-DMAC7.html)
JP2023071729A5 (cg-RX-API-DMAC7.html)
JP2010516758A5 (cg-RX-API-DMAC7.html)
JP2021525534A5 (cg-RX-API-DMAC7.html)
CN111892661A (zh) 一种嵌合抗原受体及其在制备治疗肿瘤的产品中的应用
CN115698081A (zh) 靶向bcma的嵌合抗原受体及其用途
EP4021932B1 (en) Tcr constructs specific for ebv-derived antigens
CN111875708A (zh) 一种嵌合抗原受体t淋巴细胞及其在制备治疗实体肿瘤的产品中的应用
CN108728460A (zh) 靶向gd2的嵌合抗原受体及其用途
TW202300522A (zh) 編碼對抗乙醯膽鹼受體自體抗體之嵌合受體之基因
WO2020253879A1 (zh) 一种双特异性嵌合抗原受体
JP2024502235A5 (cg-RX-API-DMAC7.html)
EP3898665B1 (en) Cd22-specific t cell receptors and adoptive t cell therapy for treatment of b cell malignancies
WO2025055790A1 (zh) 细胞因子融合蛋白及其应用
US20240018197A1 (en) Hook fusion protein for regulating the cellular trafficking of a target protein
EP0870040A2 (en) Gene delivery vehicle-targeting ligands
US11980671B2 (en) Use of bacterial voltage gated ion channels for human therapies
CN115947824A (zh) 突变的人源t细胞受体恒定区、t细胞受体及t细胞受体修饰的细胞及应用
JP2023540123A5 (cg-RX-API-DMAC7.html)
CN108484778B (zh) 人源化ghr106单克隆抗体的嵌合抗原受体构建体及核酸分子与应用
JP6018079B2 (ja) 非天然micタンパク質
JP2024516610A5 (cg-RX-API-DMAC7.html)
CA2660178C (en) Promiscuous her-2/neu cd4 t cell epitopes